Cargando…
Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development
The development of COVID-19 vaccines during the global pandemic that started in 2020 was marked by uncertainty and misinformation reflected also on social media. This paper provides a quantitative evaluation of the Uniform Resource Locators (URLs) shared on Twitter around the clinical trials of the...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703426/ https://www.ncbi.nlm.nih.gov/pubmed/36466588 http://dx.doi.org/10.1007/s10588-022-09370-3 |
_version_ | 1784839845111136256 |
---|---|
author | Horawalavithana, Sameera De Silva, Ravindu Weerasekara, Nipuna Kin Wai, N G Nabeel, Mohamed Abayaratna, Buddhini Elvitigala, Charitha Wijesekera, Primal Iamnitchi, Adriana |
author_facet | Horawalavithana, Sameera De Silva, Ravindu Weerasekara, Nipuna Kin Wai, N G Nabeel, Mohamed Abayaratna, Buddhini Elvitigala, Charitha Wijesekera, Primal Iamnitchi, Adriana |
author_sort | Horawalavithana, Sameera |
collection | PubMed |
description | The development of COVID-19 vaccines during the global pandemic that started in 2020 was marked by uncertainty and misinformation reflected also on social media. This paper provides a quantitative evaluation of the Uniform Resource Locators (URLs) shared on Twitter around the clinical trials of the AstraZeneca vaccine and their temporary interruption in September 2020. We analyzed URLs cited in Twitter messages before and after the temporary interruption of the vaccine development on September 9, 2020 to investigate the presence of low credibility and malicious information. We show that the halt of the AstraZeneca clinical trials prompted tweets that cast doubt, fear and vaccine opposition. We discovered a strong presence of URLs from low credibility or malicious websites, as classified by independent fact-checking organizations or identified by web hosting infrastructure features. Moreover, we identified what appears to be coordinated operations to artificially promote some of these URLs hosted on malicious websites. |
format | Online Article Text |
id | pubmed-9703426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-97034262022-11-28 Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development Horawalavithana, Sameera De Silva, Ravindu Weerasekara, Nipuna Kin Wai, N G Nabeel, Mohamed Abayaratna, Buddhini Elvitigala, Charitha Wijesekera, Primal Iamnitchi, Adriana Comput Math Organ Theory OriginalPaper The development of COVID-19 vaccines during the global pandemic that started in 2020 was marked by uncertainty and misinformation reflected also on social media. This paper provides a quantitative evaluation of the Uniform Resource Locators (URLs) shared on Twitter around the clinical trials of the AstraZeneca vaccine and their temporary interruption in September 2020. We analyzed URLs cited in Twitter messages before and after the temporary interruption of the vaccine development on September 9, 2020 to investigate the presence of low credibility and malicious information. We show that the halt of the AstraZeneca clinical trials prompted tweets that cast doubt, fear and vaccine opposition. We discovered a strong presence of URLs from low credibility or malicious websites, as classified by independent fact-checking organizations or identified by web hosting infrastructure features. Moreover, we identified what appears to be coordinated operations to artificially promote some of these URLs hosted on malicious websites. Springer US 2022-11-28 /pmc/articles/PMC9703426/ /pubmed/36466588 http://dx.doi.org/10.1007/s10588-022-09370-3 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | OriginalPaper Horawalavithana, Sameera De Silva, Ravindu Weerasekara, Nipuna Kin Wai, N G Nabeel, Mohamed Abayaratna, Buddhini Elvitigala, Charitha Wijesekera, Primal Iamnitchi, Adriana Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development |
title | Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development |
title_full | Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development |
title_fullStr | Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development |
title_full_unstemmed | Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development |
title_short | Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development |
title_sort | vaccination trials on hold: malicious and low credibility content on twitter during the astrazeneca covid-19 vaccine development |
topic | OriginalPaper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703426/ https://www.ncbi.nlm.nih.gov/pubmed/36466588 http://dx.doi.org/10.1007/s10588-022-09370-3 |
work_keys_str_mv | AT horawalavithanasameera vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment AT desilvaravindu vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment AT weerasekaranipuna vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment AT kinwaing vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment AT nabeelmohamed vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment AT abayaratnabuddhini vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment AT elvitigalacharitha vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment AT wijesekeraprimal vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment AT iamnitchiadriana vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment |